|Bid||8.78 x 3000|
|Ask||8.82 x 2200|
|Day's range||8.41 - 9.10|
|52-week range||0.25 - 18.77|
|Beta (5Y monthly)||4.30|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
NEW ORLEANS, October 09, 2021--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF continues to investigate Ocugen, Inc. (NasdaqCM: OCGN).
NEW ORLEANS, September 11, 2021--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into Ocugen, Inc. (NasdaqCM: OCGN).
NEW YORK, August 14, 2021--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that a class action lawsuit has been filed against Ocugen, Inc. (NASDAQ: OCGN) in the United States District Court for the Eastern District of Pennsylvania on behalf of those who purchased or otherwise acquired Ocugen publicly traded securities between February 2, 2021 and June 10, 2021, inclusive (the "Class Period"). Investors have until August 17, 2021 to apply to the